Wednesday, 28 October 2026

Journavx

 

                                                                           Sodium Channels 




Vertex Pharmaceuticals 

Navigate Trials 

Suzetrigine




Suzetrigine aka Journavx

Selective NaV 1.8 Sodium Channel Inhibitor

Approved January 30, 2025 



Mechanism Of Action 

NaV Channels And Pain





Mechanism Of Action 

Inhibitor Of  NaV Channels Causing Pain 



Theory To Practice 

Journavx



Journavx VS Novocaine 



Snapshot





























Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)